Shuxuetong injection and its peptides enhance angiogenesis after hindlimb ischemia by activating the MYPT1/LIMK1/Cofilin pathway
Preclinical pharmacology published in J Ethnopharmacol (2022)
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Shuxuetong (SXT) injection is formulated by leech and earthworm, has been widely used in the treatment of thrombotic cardiovascular and cerebrovascular diseases with remarkable clinical efficacy. AIM OF THE STUDY: The purpose of this study is to investigate the protective mechanism of SXT injection on the mice model of hindlimb ischemia, and to evaluate the angiogenic effects of SXT injection and its main active substances. MATERIALS AND METHODS: Hindlimb ischemia was induced by left femoral artery ligation. After operation, the mice were injected with saline, 10 mg/kg/d cilostazol, 37.5 mg/kg/d SXT injection, 75 mg/kg/d SXT injection and 150 mg/kg/d SXT injection via tail vein for 4 weeks. Ischemia severity was assessed using laser Doppler perfusion imaging system. Tissue recovery and capillary density were evaluated by histological and immunofluorescent staining. Vascular endothelial growth factor-A (VEGF-A) and platelet-derived growth factor (PDGF-BB) expression were measured by reverse transcription polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) analyses. Human umbilical vein endothelial cells (HUVECs) proliferation was measured using a BrdU kit and the viability of HUVECs was performed by MTT assay. Migration of HUVECs was performed by the wound healing method and a modified transwell assay. Capillary tube formation by HUVECs was examined by using Matrigel assay. Western blotting was used to detect the expressions of p-Cofilin, p-MYPT1, and p-LIMK1. RESULTS: SXT injection treatment significantly restored the blood flow and reduced tissue injury in mouse gastrocnemius muscle. SXT injection treatment increased capillary density and promoted angiogenesis in hindlimb ischemia. Moreover, SXT injection enhanced the expression of VEGF-A and PDGF-BB at both mRNA and protein levels in ischemic tissue of mice. SXT injection and its main active peptides dramatically increased the migration and capillary tube formation of HUVECs. SXT injection and its peptides enhanced protein expressions of the phosphorylation of MYPT1, Cofilin, and LIMK1. DSYVGDEAQSKR, YNELRVAPEEHP, and IQFLPEGSPVTM may act as the active components of SXT injection. CONCLUSION: SXT injection promoted angiogenesis and improved function recovery in hindlimb ischemia mice by regulation of VEGF-A/PDGF-BB. Moreover, SXT injection and its active peptides induced cell migration and tube formation in HUVECs through activating the MYPT1/LIMK1/Cofilin pathway. This study provided experimental basis for SXT injection in the treatment of ischemic diseases and revealed the effective substance of SXT injection in regulating angiogenesis, providing better evidence for the clinical application of SXT injection.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Zusammenfassung
Shuxuetong (a leech + earthworm injection) and its active peptides DSYVGDEAQSKR, YNELRVAPEEHP, and IQFLPEGSPVTM significantly restored blood flow in mouse hindlimb ischemia by activating MYPT1/LIMK1/Cofilin and increasing VEGF-A/PDGF-BB.
Warum dies für die Hirudotherapie relevant ist
Diese Studie untersuchte die Shuxuetong(SXT)-Injektion, eine traditionelle chinesische Arzneimittelformulierung, die Blutegel und Regenwurm enthält, in einem Maus-Hinterbein-Ischämiemodell sowie in menschlichen Nabelschnurvenen-Endothelzellen (HUVECs). Die SXT-Injektion stellte den Blutfluss signifikant wieder her, reduzierte die Gewebeschädigung, erhöhte die Kapillardichte und hochregulierte die VEGF-A- und PDGF-BB-Expression im ischämischen Gewebe. In HUVECs verstärkten SXT und seine identifizierten Peptide (DSYVGDEAQSKR, YNELRVAPEEHP, IQFLPEGSPVTM) Migration und Röhrenbildung über die Aktivierung des MYPT1/LIMK1/Cofilin-Signalwegs. Dies ist relevant für den ASH-Bereich, da es eine blutegelhaltige Zubereitung mit pro-angiogenen Wirkungen untersucht. Die Studie umfasst jedoch eine verarbeitete multi-komponentige injizierbare Formulierung und nicht eine lebende Blutegeltherapie oder ein gereinigtes Blutegelsekretom, und der spezifische Beitrag der Blutegelkomponente gegenüber dem Regenwurm lässt sich aus diesen Daten nicht isolieren.
Zitation
Shuxuetong injection and its peptides enhance angiogenesis after hindlimb ischemia by activating the MYPT1/LIMK1/Cofilin pathway.
Sun W et al. · Journal of ethnopharmacology, 2022
Verwandter klinischer Kontext
Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist
Zur ASH-Bibliothek hinzugefügt: May 26, 2026 · Letzte Aktualisierung der Website: 18. Juni 2026